A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Valamehr, Bahram ^a   Abujarour, Ramzey ^a   Robinson, Megan ^a   Le, Thuy ^a   Robbins, David ^a   Shoemaker, Daniel ^a   Flynn, Peter ^a  

^a Fate Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CLONE; CELL LINE; COPY NUMBER VARIATION; DIFFERENTIATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; KARYOTYPE; PLURIPOTENT STEM CELL;

EID: 84867002724     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00213     Document Type: Article

References (50)

1. Keller, G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 19, 1129-1155 (2005).
2. Saha, K. & Jaenisch, R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5, 584-595 (2009).
3. Smith, A. G. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 17, 435-462 (2001).
4. Kiskinis, E. & Eggan, K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 120, 51-59 (2010).
5. Hanna, J. et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133, 250-264 (2008).
6. Lowry, W. E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 105, 2883-2888 (2008).
7. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
8. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
9. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
10. Soldner, F. et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977 (2009).
11. Woltjen, K. et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766-770 (2009).
12. Zhou, H. et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384 (2009).
13. Zhou, W. & Freed, C. R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667-2674 (2009).
14. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26, 101-106 (2008).
15. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
16. Valamehr, B., Tsutsui, H., Ho, C. M. & Wu, H. Developing defined culture systems for human pluripotent stem cells. Regen Med 6, 623-634 (2011).
17. Mayshar, Y. et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521-531 (2010).
18. Stewart, M. H., Bendall, S. C. & Bhatia, M. Deconstructing human embryonic stem cell cultures: niche regulation of self-renewal and pluripotency. J Mol Med 86, 875-886 (2008).
19. Catalina, P. et al. Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Mol Cancer 7, 76 (2008).
20. Bock, C. et al. Reference Maps of human ES and iPS cell variation enable highthroughput characterization of pluripotent cell lines. Cell 144, 439-452 (2011).
21. Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67 (2011).
22. Hussein, S. M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-62 (2011).
23. Laurent, L. C. et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106-118 (2011).
24. Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73 (2011).
25. Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519-523 (2008).
26. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. & Brivanlou, A. H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10, 55-63 (2004).
27. Chen, G., Hou, Z., Gulbranson, D. R. & Thomson, J. A. Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell 7, 240-248 (2010).
28. Ohgushi, M. et al. Molecular pathway and cell state responsible for dissociationinduced apoptosis in human pluripotent stem cells. Cell Stem Cell 7, 225-239 (2010).
29. Watanabe, K. et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25, 681-686 (2007).
30. Xu, Y. et al. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci U S A 107, 8129-8134 (2010).
31. Nichols, J., Silva, J., Roode, M. & Smith, A. Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 136, 3215-3222 (2009).
32. Tsutsui, H. et al. An optimized small molecule inhibitor cocktail supports longterm maintenance of human embryonic stem cells. Nat Commun 2, 167 (2011).
33. Kelly, K. F. et al. beta-catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism. Cell Stem Cell 8, 214-227 (2011).
34. Huangfu, D. et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26, 1269-1275 (2008).
35. Ichida, J. K. et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5, 491-503 (2009).
36. Lin, T. et al. A chemical platform for improved induction of human iPSCs. Nat Methods 6, 805-808 (2009).
37. Yuan, X. et al. Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts. Stem Cells (2011).
38. Mei, Y. et al. Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater 9, 768-778 (2010).
39. Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 27, 851-857 (2009).
40. Zwaka, T. P. & Thomson, J. A. Homologous recombination in human embryonic stem cells. Nat Biotechnol 21, 319-321 (2003).
41. Emre, N. et al. The ROCK inhibitor Y-27632 improves recovery of human embryonic stem cells after fluorescence-activated cell sorting with multiple cell surface markers. PLoS One 5, e12148 (2010).
42. Chan, E. M. et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27, 1033-1037 (2009).
43. Sun, N. et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A 106, 15720-15725 (2009).
44. Sugii, S., Kida, Y., Berggren, W. T. & Evans, R. M. Feeder-dependent and feederindependent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc 6, 346-358 (2011).
45. Pasi, C. E. et al. Genomic instability in induced stem cells. Cell Death Differ (2011).
46. Damoiseaux, R., Sherman, S. P., Alva, J. A., Peterson, C. & Pyle, A. D. Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells. Stem Cells 27, 533-542 (2009).
47. Sugii, S. et al. Human and mouse adipose-derived cells support feederindependent induction of pluripotent stem cells. Proc Natl Acad Sci U S A 107, 3558-3563 (2010).
48. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2010).
49. Carey, B. W. et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A 106, 157-162 (2009).
50. Chin, M. H., Pellegrini, M., Plath, K. & Lowry, W. E. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7, 263-269 (2010).